Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from RBC Capital issued a price target of $221.50 for CDTX on 2025-11-14 21:13:41.The adjusted price target was set to $221.50.At the time of the announcement, CDTX...
November 14, 2025 CDTX 105.41%
Robert Brown from Lake Street issued a price target of $7.00 for PPSI on 2025-11-14 14:25:15.The adjusted price target was set to $7.00.At the time of the announcement,
November 14, 2025 PPSI -6.91%
Judah Frommer from Morgan Stanley issued a price target of $19.00 for TRVI on 2025-11-14 13:19:47.The adjusted price target was set to $19.00.At the time of the announcement,
November 14, 2025 TRVI -0.79%
from Piper Sandler issued a price target of $1.25 for TELA on 2025-11-14 13:13:00.The adjusted price target was set to $1.25.At the time of the announcement, TELA...
November 14, 2025 TELA -10.00%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| CDTX Cidara Therapeutics, Inc. | 217.71
105.41% | ||||||||||||||||||
| CMCT Creative Media & Communit | 9.25
36.43% | ||||||||||||||||||
| TOI The Oncology Institute, I | 3.97
28.90% | ||||||||||||||||||
| CNTB Connect Biopharma Holding | 2.12
26.19% | ||||||||||||||||||
| PGEN Precigen, Inc. | 4.85
25.65% | ||||||||||||||||||
| OMER Omeros Corporation | 7.87
25.32% | ||||||||||||||||||
| BZFDW BuzzFeed | 0.04
19.86% | ||||||||||||||||||
| BCAB BioAtla, Inc. | 0.79
19.70% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 0.51%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -39.95%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -9.21%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 1.69%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -0.46%